arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Kura Oncology, Inc.

KURA

$9.58 ▲ +0.30 (+3.23%) at close

19 Visible periods

29 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Kura Oncology, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $839.9M

Dividend Yield —

Revenue Growth 25.2%

Op. Margin -449.9% ↘

ROIC -165.3% ↘

FCF / Share $-0.81 ↘

Trailing P/E —

Price / Book 4.8x

FCF Yield —

Debt / Equity 0.06

info Valuation on last close. End-of-day price, Aug 7, 2026.

19-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$67.48M

↑ +25.2% —

Net Income Profit after all expenses

$-278.67M

↓ -60.2% —

Operating Margin Operating profit as % of sales

-449.9%

↓ -25.5% 0th

FCF / Share Free cash flow per share

$-0.81

↓ -151.9% —

Long-Term Debt Long-term obligations

$9.70M

↑ +1.9% —

trending_up

Bullish Indicators

Debt to EquityDebt to Equity is in the top quartile (lower is better)

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↓

Returns ↓

Financial Health →

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗
Revenue Growth YoY (%)	25.2% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+215%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	-57.4% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	2.9% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	-2.5% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-3.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-60.2% Weak ↓ Weak Declining Year-over-year change in net income	-14.0% Weak ↑ Weak Improving Year-over-year change in net income	-12.4% Weak ↑ Weak Improving Year-over-year change in net income	-4.1% Weak ↑ Weak Improving Year-over-year change in net income	-45.6% Weak ↓ Weak Declining Year-over-year change in net income	-41.9% Weak ↓ Weak Declining Year-over-year change in net income	-4.5% Weak ↑ Weak Improving Year-over-year change in net income	-70.6% Weak ↑ Weak Improving Year-over-year change in net income	-28.6% Weak ↑ Weak Improving Year-over-year change in net income	-21.8% Weak ↑ Weak Improving Year-over-year change in net income	-10953.2% Weak ↓ Weak Declining Year-over-year change in net income	-615.4% Weak ↓ Weak Declining Year-over-year change in net income	80.3% Excellent ↑ Excellent Improving Year-over-year change in net income	-437.5% Weak ↓ Weak Declining Year-over-year change in net income	-20.7% Weak ↑ Weak Improving Year-over-year change in net income	-12.0% Weak ↑ Weak Improving Year-over-year change in net income	40.5% Excellent Excellent Year-over-year change in net income	-124.5% Weak Weak Year-over-year change in net income	—
FCF Growth YoY (%)	N/M	N/M	-3.3% Weak Weak Year-over-year change in free cash flow	-3.7% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗
Operating Margin (%) (%)	-449.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3100%)	-358.5% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2490%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	-0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.2% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	-412.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3541%)	-322.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2791%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	-104.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	248.4% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.25x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.77x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.83x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.90x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗
Return on Invested Capital (%)	-165.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-46.2% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-40.8% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—	—	—	—	92.3% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	14.5% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	111.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	27.2% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	39.5% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—	—
Return on Capital (%) (%)	-41.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-25.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	-36.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—	—	—	-3219.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	-250.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—
Return on Common Equity (%) (%)	-160.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1167%)	-42.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-380%)	-38.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-356%)	-32.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-315%)	-25.8% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-272%)	-14.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-198%)	-28.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-292%)	-37.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-350%)	-44.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-396%)	-48.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-423%)	-27.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-284%)	132.3% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+782%)	23.1% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+54%)	152.4% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+916%)	39.7% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+165%)	54.6% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+264%)	107.5% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+617%)	—	-42.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-385%)

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗
Debt to Equity (x)	0.06x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-91%)	0.02x Excellent → Excellent Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-96%)	0.02x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-96%)	0.02x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-96%)	—	0.01x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-99%)	0.03x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-94%)	0.05x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-92%)	0.07x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-88%)	0.13x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-79%)	—	—	—	—	—	—	—	—	—
Interest Coverage (x)	-304.24x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-176.27x Weak Weak Operating income divided by interest expense Optimal: > 5x	-155.83x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—	-7.53x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-3.87x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-11.86x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-6.51x Weak Weak Operating income divided by interest expense Optimal: > 5x	-10.87x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—
Net Debt (USD)	$-139.40M	$-214.94M	$-27.99M	$-42.64M	$-90.67M	$-321.24M	$-18.89M	$-8.62M	$-5.87M	$-2.40M	$-15.44M	$-5.61K	$-6.57K	$-4.80K	$-6.16K	$-26.90K	$-11.14K	—	—
Debt / EBITDA (x)	-0.03x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.05x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.06x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗
Revenue per Share (USD)	$0.77	$0.63	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-3.18	$-2.02	$-2.08	$-2.03	$-1.97	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.81	$1.55	$-1.71	$-1.65	$-1.59	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$1.98	$5.29	$5.34	$6.15	$7.61	$9.23	$4.82	$4.22	$2.71	$2.94	$4.53	$-0.06	$-0.05	$-0.04	$-0.03	$-0.02	—	—	—
Tangible Book Value per Share (USD)	$1.98	$5.29	$5.34	$6.15	$7.61	$9.23	$4.82	$4.22	$2.71	$2.94	$4.53	$-0.06	$-0.05	$-0.04	$-0.03	$-0.02	—	—	—
Basic Weighted Avg Shares (shares)	87.68M	86.16M	73.23M	66.99M	66.35M	—	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗
Working Capital (USD)	$591.69M	$666.12M	$397.22M	$422.37M	$499.83M	$611.27M	$224.04M	$167.58M	$84.61M	$63.36M	$81.81M	—	—	$-95.35K	$-68.03K	$-40.99K	—	—	—
LT Debt (USD)	$9.70M	$9.52M	$9.33M	$9.16M	—	$4.25M	$7.25M	$7.50M	$5.57M	$7.32M	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$174.13M	$413.64M	$397.27M	$420.28M	$506.61M	$610.90M	$218.78M	$160.99M	$79.86M	$56.88M	$82.10M	$-154.69K	$-123.96K	$-95.35K	$-68.03K	$-40.99K	$-18.60K	$1.40K	$35.02K

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗
Sales/Revenue/Turnover (USD)	$67.48M	$53.88M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	$1.03M	$848.00K	$849.00K	$759.00K	$558.00K	$194.00K	$0.00	$10.00K	$30.00K	$31.00K	$20.00K	—	—	—	—	—	—	—	—
Net Income, GAAP (USD)	$-278.67M	$-173.98M	$-152.63M	$-135.84M	$-130.47M	$-89.62M	$-63.14M	$-60.45M	$-35.43M	$-27.56M	$-22.62M	$-204.69K	$-28.61K	$-145.35K	$-27.04K	$-22.39K	$-20.00K	$-33.62K	$-14.98K
Operating Cash Flow (USD)	$-64.06M	$134.32M	$-124.82M	$-110.06M	$-104.55M	$-69.83M	$-54.76M	$-48.66M	$-28.44M	—	—	$-169.39K	$-23.23K	$-130.20K	$-22.68K	$-19.24K	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 19 years · 69 quarters

Kura Oncology, Inc.

Analytical Summary

19-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare KURA with peers